Stock Information
Mirum Pharmaceuticals Inc (MIRM)
Ticker Symbol: MIRM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $6,406.47 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -13.6045
Revenue (TTM): $9.68 M
Dividend Yield: N/A%
ROE: -289.33%
Latest News
-
Mirum Pharmaceuticals reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Thu, May 14, 2026 4:27 PM
-
Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes
Tue, May 12, 2026 11:57 PM
-
Mirum Pharmaceuticals Announces Proposed $600M Offering Of Notes Due 2032
Tue, May 12, 2026 4:19 PM
-
Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
Tue, May 12, 2026 4:02 PM
-
Mirum Pharmaceuticals: A Rare Disease Platform Becoming Bigger Than Its First Franchise
Tue, May 12, 2026 1:21 PM
-
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
Tue, May 12, 2026 8:07 AM
Key Financials
Financial data not available
